加州太平洋生物科学公司 PACB 深 沪
等待开盘 08-19 09:30:00 美东时间
1.14
-0.070
-5.79%
华盛通- 最 高1.205
- 今 开1.19
- 成交量 481.80万股
- 最 低 1.12
- 昨 收 1.21
- 总市值 3.54亿
- 52周最高 2.73
- 市盈率 静 --
- 换手率 1.55%
- 52周最低 1.07
- 委 比 -99.74%
- 总股本 3.11亿
- 历史最高 53.69
- 量 比 0.67
- 振 幅 7.02%
- 历史最低 0.8511
- 每 手 1
- 风险率 0.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PacBio Restructures Operations and Appoints New CEO
Pacific Biosciences ( ($PACB) ) has shared an announcement. On July 30, 2026, P...
08-06 05:14
Pacific Biosciences Lowers FY2026 Sales Guidance from $165.000M-$175.000M to $155.000M-$165.000M vs $166.790M Est
Pacific Biosciences (NASDAQ:PACB) lowers FY2026 sales outlook from $165.000 million-$175.000 million to $155.000 million-$165.000 million vs $166.790 million estimate.
08-06 04:29
PacBio Appoints Mark Van Oene as President and Chief Executive Officer
PacBio announced that Christian Henry will transition from President and CEO, with Mark Van Oene succeeding him effective August 5, 2026. Van Oene, previously COO, has been instrumental in advancing PacBio's operational execution, commercial strategy, and AI-related product improvements. Henry will remain on the Board and serve as a business advisor. Van Oene is expected to drive PacBio's growth in clinical markets and AI-related solutions.
08-05 20:08
Pacific Biosciences Announces Resignation of Board Member
The latest update is out from Pacific Biosciences ( ($PACB) ). On July 8, 2026,...
07-10 05:20
Blank Bio Closes $7.2M Seed Financing And Strategic Collaboration With Pacific Biosciences
Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomesBlank Bio, an applied AI research lab training foundation models for RNA, today announced
05-19 21:07
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Pacific Biosciences Balances Growth Hopes and Margin Strain
Pacific Biosciences (($PACB)) has held its Q1 earnings call. Read on for the ma...
05-09 08:52
Pacific Biosciences of California shares are trading lower after the company reported worse-than-expected Q1 sales results.
Pacific Biosciences of California shares are trading lower after the company re...
05-08 23:52
PacBio tumbles after narrowing full-year revenue guidance
Pacific Biosciences of California (PACB) shares fell 16% after the company reported Q1 results that included a wider-than-expected revenue miss and weaker profitability metrics. PacBio reported Q1 non...
05-08 22:51
Pacific Biosciences Sees FY2026 Sales $165.000M-$175.000M vs $173.371M Est
Pacific Biosciences (NASDAQ:PACB) sees FY2026 sales of $165.000 million-$175.000 million vs $173.371 million analyst estimate.
05-08 04:14
